Lead (Pb) exposure has been a major public health concern for a long time now due to its
permanent adverse effects on the human body. The process of lead toxicity has still not been …

Acute myeloid leukemia (AML) exhibits pronounced heterogeneity and chemotherapy
resistance. Aberrant programmed cell death (PCD) implicated in AML pathogenesis …

Vacuolar ATPase (V-ATPase) is regarded as a possible target in cancer treatment. It is
expressed in primary acute myeloid leukemia cells (AML), but the expression varies …

Introduction C-type lectin domain family 11 member A (CLEC11A) was characterized as a
growth factor that mainly regulates hematopoietic function and differentiation of bone cells …

Beta-cell dysfunction is a hallmark of disease progression in patients with diabetes.
Research have been focused on maintaining and restoring beta-cell function during …

Acute myeloid leukemia (AML) is an aggressive and lethal cancer of the blood, which leads
to the death of over 11,000 patients in the United States each year. Research on identifying …

Objective Previous studies have partly discussed the roles of inflammatory cytokines in
obesity and systemic lupus erythematosus (SLE), but the causal relationship among …

Introduction The significance of ligand-receptor (LR) pair interactions in the progression of
acute myeloid leukemia (AML) has been the focus of numerous studies. However, the …

The incidence rate and mortality rate of colorectal cancer (CRC) ranks third and second
globally. Cancer-associated fibroblasts (CAFs) are the major constituent of the stromal cells …

The typical genomic feature of acute myeloid leukemia (AML) M3 subtype is the fusion event
of PML/RARα, and ATRA/ATO-based combination therapy is current standard treatment …